Systemic effects of a short course of betamethasone compared with high-dose inhaled budesonide in early childhood asthma.

Author: HedlinG, RydenA C, SvedmyrJ

Paper Details 
Original Abstract of the Article :
Forty children aged 1-3 y completed a placebo-controlled study on the effects of 10 d of inhaled budesonide for asthma caused by respiratory tract infection. The effects on symptoms were significantly better in the active than in the placebo group. In 20 of these children the systemic effects of hig...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/08035259950170592

データ提供:米国国立医学図書館(NLM)

Systemic Effects of Betamethasone and Inhaled Budesonide in Childhood Asthma

This research compares the systemic effects of short-term oral betamethasone and high-dose inhaled budesonide in children with asthma. The study aimed to assess the impact of these medications on systemic cortisol levels and bone markers, providing insights into their potential side effects.

The study found that short courses of oral betamethasone produced significant systemic effects, while high doses of inhaled budesonide did not. The study measured various markers of systemic effects, including serum and urine cortisol levels and bone markers, observing a decrease in these markers after betamethasone treatment but not after budesonide treatment.

Inhaled Budesonide: A Safer Alternative for Childhood Asthma

The findings of this study suggest that inhaled budesonide may be a safer alternative to oral betamethasone for short-term asthma treatment in children. While inhaled budesonide effectively manages asthma symptoms, it appears to have minimal systemic effects, reducing the potential for side effects on bone growth and other physiological functions.

Implications for Childhood Asthma Management

This research offers valuable information for managing childhood asthma, highlighting the importance of considering potential systemic effects of medications. The findings suggest that inhaled budesonide may be a preferable option for short-term treatment, especially in young children where minimizing systemic effects is crucial. Like a camel caravan carefully choosing its route through the desert to avoid dangerous terrain, healthcare providers must navigate the potential side effects of medications to ensure the well-being of their young patients.

Dr. Camel's Conclusion

This research, like a cool breeze in the desert, provides a refreshing perspective on managing childhood asthma. While oral betamethasone, like a desert mirage, might appear to offer immediate relief, inhaled budesonide, like a reliable oasis, provides a safer and more sustainable approach to managing asthma symptoms in children. This research is a valuable reminder to always consider the potential side effects of medications and to choose a path that prioritizes the health and well-being of our children.

Date :
  1. Date Completed 1999-05-05
  2. Date Revised 2019-08-22
Further Info :

Pubmed ID

10090547

DOI: Digital Object Identifier

10.1080/08035259950170592

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.